19 November 2021

READ MOREAkston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine

5 August 2021

READ MOREAkston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine

21 July 2021

READ MOREAkston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-stable COVID-19 Vaccine at Global Scale

8 July 2021

READ MOREAkston Biosciences Announces Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate

24 July 2019

READ MOREHelmsley Charitable Trust and Akston Biosciences Corporation Extend Partnership